1214 event(s) found
Journée sur les cancers du pancréas et hépatobiliaires
Regional scientific day in Strasbourg on pancreatic and hepatobiliary cancers listed by Cancéropôle Est, with a call for abstracts.
16th Shanghai Urologic Oncology Conference & CACA Committee of Male Genital System Tumors Annual Meeting (第十六届上海泌尿肿瘤学术大会暨中国抗癌协会男性生殖系统肿瘤专委会年会)
Annual Shanghai meeting on urologic and genitourinary oncology, held jointly with the yearly congress of the China Anti-Cancer Association committee on male genital system tumours. It covers prostate, bladder, kidney and other genitourinary cancers.
68th ASH Annual Meeting & Exposition
More information coming soon..
22e Congrès de la SoFOG (Société Francophone d'Oncogériatrie)
22nd congress of the French-speaking geriatric oncology society, held simultaneously at CHU des Abymes (Guadeloupe) and the Cité Mondiale in Bordeaux with remote access to plenaries; themes are hormone-dependent tumours in women and men and risk factors in geriatric oncology.
ESMO Immuno-Oncology & Advanced Therapies Congress 2026
Hybrid international ESMO congress spanning cancer immunology, immunotherapy, cell therapies, vaccines, biomarkers and advanced therapeutic strategies, for clinicians, scientists and translational researchers.
RICAI 2026
Venez profiter de l’effet boost de la RICAI les 14 et 15 décembre 2026 ! Chaque année les participants nous témoignent du plaisir qu’ils ont eu à participer à cette parenthèse scientifique hivernale qu’est la RICAI, et nous disent à quel point ils en ressortent motivés et renforcés. Les retours sont unanimes et saluent la diversité des thématiques (chacun s’y retrouve), la qualité des présentations, l’atmosphère studieuse (mais détendue), et la richesse des échanges qui tient à la transdisciplinarité du congrès. Car tous les acteurs de la lutte contre les maladies infectieuses y sont représentés : cliniciens, microbiologistes, épidémiologistes, hygiénistes, pharmacologues, pharmaciens, partenaires industriels… et les sessions construites pour favoriser l’échange des connaissances et compétences. Les sociétés savantes (SPILF, SFM, SF2H…) ont chacune leur congrès, mais sont également toutes parties prenantes de la RICAI, justement pour ce que cette réunion offre comme possibilités de complémentarité, de décloisonnement et de partage. Vous cherchez des mises au point ? A connaitre les dernières innovations ? A mieux connaître les outils diagnostiques et thérapeutiques ? Un briefing sur les épidémies en cours ? Une table ronde pour échanger avec des experts ? A disposer des communications après le congrès What else ? Autour des communications scientifiques, c’est aussi toute une vie et une émulation qui sont palpables dans les allées, sur les stands, et autour des posters : rencontres, initiation de projets, partage d’expériences, échange de scoops, ou tout simplement réseau amicaux à réactiver… qui comptent aussi dans le plaisir de participer à la RICAI.
eLCH-Webinar - Weihnachtsedition 2026 - Plasmazellneoplasien
Live webinar of the DGHO eLearning Curriculum Haematology (eLCH) on the cytomorphology and diagnosis of plasma cell neoplasms.
Journée Scientifique Cancer-Cerveau-Cognition (Axe 4 du CNO)
Scientific day of Cancéropôle Nord-Ouest axis 4 in Paris on cancer, brain and cognition, including cancer-related cognitive impairment.
Highlights vom ASH - Hämatologie 2026: New Orleans in 10 Minuten
DGHO virtual session condensing haematology highlights from the ASH 2026 Annual Meeting into short summaries.
ASH-Kongress Highlights 2026 (Live-Webinar)
German live webinar under DGHO patronage summarising key results from the ASH 2026 Annual Meeting.
Onkopedia-Webinar: Best of ASH 2026
DGHO Onkopedia webinar reviewing the most relevant ASH 2026 data for clinical practice.
29. Münchner LymphomWorkshop
Twenty-ninth Munich lymphoma workshop, a two-day seminar on lymphoma diagnosis and treatment.
Wrap-Up Hämato-Onkologie ASH 2026
Vienna meeting summarising the key haemato-oncology data presented at the ASH 2026 Annual Meeting.
CACA Committee of Integrative Rehabilitation for Hematologic Tumors Quarterly Meeting & Lymphoma Specialty Training Course (中国抗癌协会血液肿瘤整合康复专委会季度会议暨淋巴瘤专科培训班)
Training course on lymphoma diagnosis and management organised by the CACA committee on integrative rehabilitation of haematologic tumours, held alongside the committee's quarterly meeting in Quanzhou, Fujian.
3rd Shanghai Medical Association Radiation Oncology Branch Symposium on Radiotherapy Physics and Technology 2026 (2026第三届上海市医学会肿瘤放疗分会放疗物理与技术专题会)
One-day symposium of the Shanghai Medical Association radiation oncology branch dedicated to radiotherapy physics and technology. Regional (municipal) society meeting.
Neues von den großen hämatologischen Kongressen 2026 (Post-ASH Rostock)
Post-ASH update meeting in Rostock on news from the major 2026 haematology congresses, run via OSHO services.
Haematological Malignancy Diagnostic Service (HMDS) Course 2027
Two-day course on the integrated laboratory diagnosis of haematological malignancies (haematopathology, flow cytometry and molecular diagnostics), listed by the European Association for Haematopathology.
AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy
The goal of this conference is to convene experts in cancer biology, immunotherapy, and radioligand therapy (RLT) to discuss approaches to treating cancer with radioligand therapies and explore synergies with other treatments. With significant effort and interest in radioligand therapy by academia, industry, and government, paradigm-changing studies have demonstrated that combining molecular imaging and RLT has the possibility to dramatically impact cancer treatment. However, the major limitation for the further development of this field is a lack of fundamental knowledge of the mechanism(s) of action of systemic therapeutic isotopes with tumors, the tumor microenvironment, and the immune system. This conference is needed to engage experts from these diverse areas to not only educate on the state-of-the-art in radiotheranostics, but also to leverage the knowledge of cancer biologists, clinical oncologists, and immunologists to understand how RLT approaches work and how to overcome their limitations to drive the development of next generation therapies. Advancing RLT requires multi-disciplinary effort, with critical input from experts in radiochemistry, instrumentation, nuclear physics, and radiation biology. An unmet need in the field is advanced understanding of systemic radiobiology and cancer immunology as linked to therapeutic isotopes to fill gaps in knowledge across these domains. This AACR conference will focus on bringing together experts in these areas to discuss: 1) novel mechanisms of action of how systemic beta- and alpha-emitting isotopes interact with tumors, TME and the whole body to affect cures; 2) how RLT engages the immune system to mediate therapeutic efficacy; 3) rational approaches to treating cancer with novel isotopes and repurposed radioligand therapies; and 4) novel combinations and synergies with targeted and cellular therapies as well as external beam radiation, leveraging the strengths of each. Understanding how RLT interacts with the TME and the immune system are key to advancing novel therapies to treat an array of cancers.
LUGPA 2027 Global Prostate Cancer Congress
Global Prostate Cancer Congress of the Large Urology Group Practice Association (LUGPA), designed with Specialty Networks.
45th Annual J.P. Morgan Healthcare Conference
The largest healthcare investment symposium, gathering industry leaders, emerging companies and investors; the week hosts many satellite partnering events in San Francisco (invitation-only main conference).
2027 Tutorial on Neoplastic Hematopathology
Five-day CME tutorial on the diagnosis of haematolymphoid neoplasms through lectures, case presentations and discussions, directed by Daniel A. Arber (University of Chicago).
Cell & Gene State of the Industry Briefing 2027
Annual briefing by the Alliance for Regenerative Medicine presenting the financial, clinical and regulatory state of the cell and gene therapy sector, held in San Francisco during the J.P. Morgan Healthcare Conference week.
Biotech Showcase 2027
19th annual investor and partnering conference held during JPM week: 400+ presenting companies from seed stage to multinationals, investors representing $400bn+; virtual part on 19-20 January 2027.
Connected in Lung Cancer 2027
One-day Vienna meeting on lung cancer.